1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-2735
  5. NDC Package Code: 70518-2735-7 Clindamycin Hydrochloride

NDC Package 70518-2735-7 Clindamycin Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-2735-7
Package Description:
14 CAPSULE in 1 BOTTLE, PLASTIC
Product Code:
70518-2735
Proprietary Name:
Clindamycin Hydrochloride
Usage Information:
Clindamycin hydrochloride capsules are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin hydrochloride capsules are also indicated in the treatment of seri­ous infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING, before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis, and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastroin­testinal tract); infections of the female pelvis and geni­tal tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection. Streptococci: Serious respiratory tract infections; seri­ous skin and soft tissue infections. Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections. Pneumococci: Serious respiratory tract infections. Bacteriologic studies should be performed to deter­mine the causative organisms and their susceptibility to clindamycin. To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride and other antibacterial drugs, clindamycin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacte­ria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
11-Digit NDC Billing Format:
70518273507
Labeler Name:
Remedyrepack Inc.
Sample Package:
No
FDA Application Number:
ANDA065442
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
05-12-2020
End Marketing Date:
04-04-2025
Listing Expiration Date:
04-04-2025
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
70518-2735-020 CAPSULE in 1 BLISTER PACK
70518-2735-116 CAPSULE in 1 BOTTLE, PLASTIC
70518-2735-230 CAPSULE in 1 BOTTLE, PLASTIC
70518-2735-321 CAPSULE in 1 BOTTLE, PLASTIC
70518-2735-428 CAPSULE in 1 BLISTER PACK
70518-2735-530 CAPSULE in 1 BLISTER PACK
70518-2735-621 CAPSULE in 1 BLISTER PACK

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70518-2735-7?

The NDC Packaged Code 70518-2735-7 is assigned to a package of 14 capsule in 1 bottle, plastic of Clindamycin Hydrochloride, labeled by Remedyrepack Inc.. The product's dosage form is and is administered via form.

Is NDC 70518-2735 included in the NDC Directory?

No, Clindamycin Hydrochloride with product code 70518-2735 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Remedyrepack Inc. on May 12, 2020 and its listing in the NDC Directory is set to expire on April 04, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70518-2735-7?

The 11-digit format is 70518273507. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170518-2735-75-4-270518-2735-07